Literature DB >> 15051743

Assessment of visual analog versus categorical scale for measurement of osteoarthritis pain.

Mordechai Averbuch1, Meyer Katzper.   

Abstract

There is disagreement in the literature regarding which scales to use in pain measurement. The difference has usually been between nonverbal scales, such as visual analog scales and verbal ones, which usually provide only a limited number of response categories. A 12-week, randomized, double-blind naproxen sodium (500 mg bid) and placebo-controlled trial using the hip osteoarthritis (OA) flare-up pain mode, in which pain was measured on both visual analog and categorical scales simultaneously, was analyzed. The authors found a good correlation (> 0.995) between the time-series average of the unconstrained visual analog scale and a 5-point categorical scale pain measurement in the osteoarthritis pain model in both active and placebo treatment arms. However, for individuals, there is a wide range of VAS responses for each categorical score, with overlaps between categories. The visual analog and categorical scales appear as effective in determining average osteoarthritis pain. However, a combined metric scale for pain measurement that provides the subject with multiple cues may improve communication and concordance between scales for individual pain determination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051743     DOI: 10.1177/0091270004263995

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  22 in total

1.  Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.

Authors:  Clapton Dias; Bassam Abosaleem; Caroline Crispino; Bing Gao; Adam Shaywitz
Journal:  AAPS PharmSciTech       Date:  2015-02-19       Impact factor: 3.246

2.  Supporting the Self-Management of Chronic Pain Conditions with Tailored Momentary Self-Assessments.

Authors:  Phil Adams; Elizabeth L Murnane; Michael Elfenbein; Elaine Wethington; Geri Gay
Journal:  Proc SIGCHI Conf Hum Factor Comput Syst       Date:  2017-05

3.  Comparing quantification of pain severity by verbal rating and numeric rating scales.

Authors:  Marcel Dijkers
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

4.  Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.

Authors:  Staci Martin; Shawn Nelson Schmitt; Pamela L Wolters; Brittany Abel; Mary Anne Toledo-Tamula; Andrea Baldwin; Rikard K Wicksell; Melinda Merchant; Brigitte Widemann
Journal:  Pain Med       Date:  2014-11-06       Impact factor: 3.750

5.  Rethinking Residue: Determining the Perceptual Continuum of Residue on FEES to Enable Better Measurement.

Authors:  Jessica M Pisegna; Asako Kaneoka; Rebecca Leonard; Susan E Langmore
Journal:  Dysphagia       Date:  2017-08-30       Impact factor: 3.438

6.  Evaluation of the temperament and character properties of patients with ankylosing spondylitis.

Authors:  F Gokmen; K Altinbas; A Akbal; M Celik; Y Savas; E Gökmen; H Reşorlu; A Karaca
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

7.  Effectiveness of submucosal dexamethasone to control postoperative pain & swelling in apicectomy of maxillary anterior teeth.

Authors:  Shahzad Ali Shah; Irfanullah Khan; Humera Shahzad Shah
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

8.  Anterior vaginal wall tenderness (AVWT) as a physical symptom in chronic pelvic pain.

Authors:  John D Paulson; Joseph N Paulson
Journal:  JSLS       Date:  2011 Jan-Mar       Impact factor: 2.172

9.  De novo pudendal neuropathy after TOT-O surgery for stress urinary incontinence.

Authors:  John D Paulson; James Baker
Journal:  JSLS       Date:  2011 Jul-Sep       Impact factor: 2.172

10.  The relationship between interstitial cystitis and endometriosis in patients with chronic pelvic pain.

Authors:  John D Paulson; Melissa Delgado
Journal:  JSLS       Date:  2007 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.